|
|
Blood, 1 September 2008, Vol. 112, No. 5, pp. 2004-2012.
Prepublished online as a Blood First Edition Paper on May 15, 2008; DOI 10.1182/blood-2007-11-123596.
Previous Article | Next Article 
Submitted November 14, 2007
Accepted February 24, 2008
Primary cystic lung light chain deposition disease : a clinicopathologic entity derived from unmutated B cells with a stereotyped IGHV4-34/IGKV1 receptor
Magali Colombat, Herve Mal, Christiane Copie-Bergman, Jacques Diebold, Diane Damotte, Patrice Callard, Michel Fournier, Jean-Pierre Farcet, Marc Stern, and Marie-Helene Delfau-Larue*
APHP, Hopital Tenon, Service d'anatomie pathologique, 7520 Paris, France
APHP, Hopital Bichat, Service de pneumologie, 75018 Paris, France
APHP, Hopital Henri Mondor, Departement de Pathologie, Creteil, F-9400, France
APHP, Hotel Dieu, Service d'anatomie pathologique, 75004, Paris, France
APHP, Hopital Europeen Georges Pompidou, Service d'anatomie pathologique, 75015 Paris, France
AP-HP, Hopital Henri Mondor, Service d'immunologie biologique, INSERM, U841 equipe 9, Universite Paris 12, Faculte de Medecine, Creteil, F-9400, France
Hopital Foch, Service de pneumologie, 92151 Suresnes, France
* Corresponding author; email: marie-helene.delfau{at}hmn.aphp.fr.
We have recently described a new form of light chain deposition disease (LCDD) presenting as a severe cystic lung disorder requiring lung transplantation. There was no bone marrow plasma cell proliferation. Because of the absence of disease recurrence after bilateral lung transplantation and of serum free light chain ratio normalization after the procedure, we hypothesized that monoclonal light chain synthesis occurred within the lung. The aim of this study was to look for the monoclonal B-cell component in three patients with cystic lung LCDD. Histological examination of the explanted lungs showed diffuse non-amyloid light chain deposits associated with a mild lymphoid infiltrate mainly composed of small CD20+, CD5-, CD10- B lymphocytes arranged in nodules reminiscent of bronchus-associated lymphoid tissue. Using PCR, we identified a dominant B-cell clone in the lung in the three studied patients. The clonal expansion of each patient shared a unmutated antigen receptor variable region sequence characterized by the use of VH4-34 and VK1 gene family with heavy and light chain CDR3 sequences of more than 80% amino acid identity, a feature evocative of an antigen-driven process. Combined with clinical and biological data, our results strongly argue for a new antigen-driven primary pulmonary lymphoproliferative disorder.

CiteULike Connotea Del.icio.us Digg Reddit Technorati What's this?
|
|